Summary: Immunotherapy is transforming the treatment landscape for triple-negative breast cancer. Through patient cases, Drs. Ruth O’Regan (medical oncologist, University of Rochester) and Jacob Kettle (Pharmacist, University of Missouri) discuss the application of novel treatment options. If you liked this episode, please subscribe. Learn more at https://elearning.asco.org, or email us at education@asco.org.
